|
|
|
|
|
|
|
07.05.26 - 13:54
|
Insmed Posts Narrower Loss In Q1 (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Insmed (INSM) reported a first quarter net loss of $163.6 million, or $0.76 per share, compared to a net loss of $256.6 million, or $1.42 per share, a year ago. Product reve......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.04.26 - 13:02
|
Insmed to Present at May 2026 Investor Conferences (PR Newswire)
|
|
|
BRIDGEWATER, N.J., April 30, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will......
|
|
|
|
|
10.04.26 - 13:54
|
Here Are Friday′s Top Wall Street Analyst Research Calls: Autodesk, Delek US Holdings, Insmed, Nike, Nutanix, ServiceNow, Shake Shack, Southern Copper, Veeva Systems, and More (24/7 Wall St.)
|
|
|
Pre-Market Stock Futures: The futures are trading mixed as we approach the end of one of the most volatile and wild trading weeks in recent memory. After starting the day lower on Thursday as mixed reports on the success of the ships passing through the Strait of Hormuz rolled in, stocks gained momentum as the ... Here Are Friday's Top Wall Street Analyst Research Calls: Autodesk, Delek US Holdings, Insmed, Nike, Nutanix, ServiceNow, Shake Shack, Southern Copper, Veeva Systems, and More...
|
|
|
|
|
|
|
|
|
|
|
07.04.26 - 22:03
|
Insmed Provides Clinical Update on Phase 2b CEDAR Study (PR Newswire)
|
|
|
—Study Did Not Meet Primary or Secondary Efficacy Endpoints; Insmed Will Discontinue HS Program— —Safety Was Consistent with Previous Studies and No New Safety Signals Were Identified for Either Dose of Brensocatib— BRIDGEWATER, N.J., April 7, 2026 /PRNewswire/ -- Insmed Incorporated......
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
